Navigation Links
Technology reveals 'lock and key' proteins behind diseases

ue. "Like lock and key, if two proteins interact with one another, it is safe to assume they participate or regulate the same cellular process," explains Stagljar. "Identifying new interactors for ABC transporters may reveal unanticipated aspects of how these transporters function and help researchers gain clues for fighting disease and drug resistance."

Using iMYTH, the Stagljar lab identified six proteins that interact with and presumably communicate with the ABC transporter Ycf1p, a yeast version of the human proteins CFTR and MRP. These newly discovered protein interactors represent novel potential pharmaceutical targets. Through a series of biochemical and genetic tests, the researchers discovered that one of these interactors, Tus1p, regulates Ycf1p transporter function in a completely novel way to stimulate its ability to remove toxins from the cell.

"The more we learn about membrane proteins, the better we can use this knowledge for pharmacological and clinical applications," Stagljar says. "We work by putting together biochemical processes piece by piece like a puzzle. Hopefully soon we will have a complete picture of how many other diseases such as breast cancer, heart diseases, arthritis and schizophrenia are caused by mutations in various human membrane proteins."
'"/>

Source:University of Toronto


Page: 1 2

Related biology news :

1. Breakthrough Microarray-based Technology for the Study of Cancer
2. Affymetrix Licenses Microfluidics Technology From Caliper Life Sciences
3. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
4. Technology for monitoring fetal oxygen during labor offers no apparent benefit
5. Technology exists to keep E. coli out of food
6. A bacterial genome reveals new targets to combat infectious disease
7. First real-time view of developing neurons reveals surprises, say Stanford researchers
8. Examination of internal wiring of yeast, worm, and fly reveals conserved circuits
9. NYU study reveals how brains immune system fights viral encephalitis
10. Study reveals new technique for fingerprinting environmental samples
11. Study reveals dramatic difference between breast cancers in US and Africa
Post Your Comments:
(Date:10/10/2008)..., MARSHFIELD, MILWAUKEE, MADISON Governor Jim D...een four Wisconsin research institutions to advanc...that proactively addresses diseases. The Wisconsin...ffort among the Marshfield Clinic, Medical College...l of Medicine and Public Health (UWSMPH) and UW-Mi...
(Date:10/10/2008)... New Haven, Conn. Yale scientists have created n... electronics that are both sensitive and specific ...detection, according to a report in Nano Letters ...y highly specific antigens signatures of bacteria... cells are activated, they produce acid, and gener...
(Date:10/9/2008)... Convenient online registration to the IOF World ...ed rates, is available only until October 31, 2008...ration, please visit http://www.iofbonehealth.org...es are available for participants from non-OECD co...8 only on-site registration, at higher rates, will...
(Date:10/9/2008)... , Will climate change exceed life,s ability to r...in the Oct. 10, 2008 issue of the journal, Scienc...ostered by the Smithsonian Tropical Research Insti... , As an extremely diverse region of rainforest a...ose as a result of global warming. Some disagree, ...
Breaking Biology News(10 mins):Governor Doyle announces historic genomic research collaboration 2Sensitive nanowire disease detectors made by Yale scientists 2Smithsonian perspective: Biodiversity in a warmer world 2Dartmouth researchers advance cellulosic ethanol production 7558 1Dartmouth researchers advance cellulosic ethanol production 7558 2Carbon molecule with a charge could be tomorrows semiconductor 7557 1Carbon molecule with a charge could be tomorrows semiconductor 7557 2Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 1Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 2Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 3Mylan to Retain Dey L P Its Specialty Pharmaceutical Subsidiary 26164 4Encouraging Gene Therapy Results in Genetic Form of Blindness 2990 1Encouraging Gene Therapy Results in Genetic Form of Blindness 2990 2Encouraging Gene Therapy Results in Genetic Form of Blindness 2990 3
...ditions early in the year mean that 2006 is shapin...s in almost four decades, according to Art Shapiro..., That,s a turnaround from last spring, when milli...he Central Valley. But other species have seen ste...om the region altogether. , "It has been the wors...
...ies that mimic the way insects, plants and animals...ur dependence on energy, according to new research... , When faced with engineering difficulties, such ... up to 70 per cent of man-made technologies manipu...order to resolve the problem. , However, new rese...
...ucted by Delft University of Technology has brough...friendly fuel bio-ethanol a great deal closer to f... was an important factor in this. His research in ...f certain sugars from agricultural waste to ethano...ee for his research into the subject. , The searc...
...lth & Science University study is adding crede...is what bonds stem cells with bone marrow cells to... School of Medicine found that transplanted cells ...tinal stem cells of both normal and diseased tissu...ls, known as the epithelium. The findings, reporte...
Other Biology News:Where have all the butterflies gone? 2Copying nature could save us energy, study shows 2Producing bio-ethanol from agricultural waste a step closer 2OHSU study says stem cell 'fusion' occurs in tumors 2OHSU study says stem cell 'fusion' occurs in tumors 3
(Date:10/10/2008)...ss., Oct. 10 /- Boston Scie...t has received approval from the,U.S. Food and Dru...tion,TAXUS(R) Liberte(R) Paclitaxel-Eluting Corona...AXUS Liberte stent early next month in the United,...f its TAXUS(R),Expresss2(TM) Atom(TM) Paclitaxel-E...
(Date:10/10/2008)...iangsu, CHINA, Oct. 10 /Xinhua-- Beik...ch.com ) a global leader in,stem cell research an...nced,today it has signed eight separate mutual coo...ld,s most outstanding stem cell research organizat...tablished a "Stem Cell Expert,Advisory Committee" ...
(Date:10/10/2008)..., Del., Oct. 10 /- AstraZen... and Drug Administration (FDA) has,approved once-d...-Release,Tablets for the acute treatment of the de..., the manic and mixed episodes associated with bip...bipolar I disorder as adjunctive,therapy to lithiu...
(Date:10/10/2008)... Md., Oct. 10 /- EntreMed, ...cal company developing,therapeutics for the treatm... today that Thomas H. Bliss, Jr., EntreMed,s Senio...nt, will present a Company,overview at the 16th An...ng,held October 12-14, 2008 in London, United King...
Breaking Biology Technology:Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 2Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent 3Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9EntreMed to Present at BioPartnering Europe Conference 2EntreMed to Present at BioPartnering Europe Conference 3
...ditor,s note: John Wade, VP/CIO, Saint Luke,s Heal...r at the annual Digital Healthcare Conference Ma...om his Kansas City office and offered a candid ass...ogy. , , WTN : What are the key remaining barrier..., , John Wade Wade: I think there are a couple...
...itor,s note: This is Part II of a three-part seri...Part I outlined the challenge facing businesses, a...n companies can do - and are doing - to address th...he estimates are accurate, about 10 percent of all... this year, and then the IT labor shortage will ki...
...When I last left you, it was in the middle of a we...ssion to open up a new trade office in that countr...both New and Old), the ancient capitol of Agra (ho...oved on to Mumbai (Bombay) for the last part of th...ons and key activities that the trade mission perf...
...Judy Lemke Green Bay, Wis. - Whenever the title..., the technologist usually is an established part ...ured out of retirement by Schneider National fol... , ,Lemke, executive vice president and CIO for th...n, logistics, and intermodal services, was recruit...
Other Biology Technology:Visions: Wade offers straight talk on e-medical records 2Visions: Wade offers straight talk on e-medical records 3Visions: Wade offers straight talk on e-medical records 4Visions: Wade offers straight talk on e-medical records 5IT workforce development: A little workforce planning goes a long way 2IT workforce development: A little workforce planning goes a long way 3IT workforce development: A little workforce planning goes a long way 4IT workforce development: A little workforce planning goes a long way 5A Midwest passage to India, Part II 2A Midwest passage to India, Part II 3A Midwest passage to India, Part II 4A Midwest passage to India, Part II 5A Midwest passage to India, Part II 6A Midwest passage to India, Part II 7A Midwest passage to India, Part II 8CIO Leadership Series: Judy Lemke, Schneider National 2CIO Leadership Series: Judy Lemke, Schneider National 3CIO Leadership Series: Judy Lemke, Schneider National 4CIO Leadership Series: Judy Lemke, Schneider National 5
Request Info
R26.4C
Chicken polyclonal to Opsin 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: YEDSTHASIFTYT, corresponding to amino acids 14/26 of Mouse Green cones Opsin 1; and synthetic
...W x H): 17 3/4" x 8 15/16" x 5 5/16"18.7 lbsCapa...trol: Programmable 30 - 99C Automated denaturation...ocols 3 operating modes (Denaturation/Hybridizatio...d temperature ramp-up from 37 - 95C and cooling fr...
Biology Products: